The content on this site is intended for healthcare professionals only
Dr Chiswili Yves Chabu speaks to ecancer about immunoprevention and early detection of lung cancer in Africa.
Initially, he talks about the challenges to lung cancer detection and prevention in Africa. He then talks about the LUNG-GUARD platform and its goals and objectives.
He also touches upon why early detection is important and what impact do resource-constraints have in this setting.
First-line use of tepotinib in METex14 NSCLC: A patient-centered journey
I-DXd shows strong brain metastasis responses in extensive-stage small cell lung cancer with manageable safety
Tarlatamab improves survival over chemo in 2L SCLC regardless of prior immunotherapy or chemo
Sacituzumab tirumotecan improves progression-free and overall survival in EGFR-TKI resistant NSCLC
Zongertinib shows high response rates in first-line HER2-mutant advanced NSCLC
Osimertinib plus chemo improves survival across high-risk subgroups in EGFR-mutated aNSCLC
WCLC 2025: Latest in EGFR positive NSCLC
Key insights from lung cancer research at ASCO 2025
ELCC 2025: Latest in EGFR positive NSCLC
